Spruce Biosciences, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
SPRB Nasdaq 2830 www.sprucebiosciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Spruce Biosciences, Inc.

Spruce Biosciences (SPRB) Upgraded to Buy: Here's Why - Dec 13th, 2024 5:00 pm
Penny Stock Spruce Biosciences Winds Down Tildacerfont Studies For Rare Genetic Disorder - Dec 11th, 2024 1:21 pm
Spruce Biosciences Announces Topline Results from CAHmelia-204 in Adult CAH and CAHptain-205 in Adult and Pediatric CAH - Dec 10th, 2024 9:01 pm
Spruce Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Nov 14th, 2024 12:57 pm
Spruce Biosciences Reports Q3 2024 Earnings and Updates - Nov 13th, 2024 3:59 am
Spruce Biosciences, Inc. (SPRB) Reports Q3 Loss, Lags Revenue Estimates - Nov 11th, 2024 2:10 pm
Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - Nov 11th, 2024 1:00 pm
Spruce Biosciences to Participate in the Guggenheim Securities Healthcare Innovation Conference - Oct 28th, 2024 8:01 pm
Spruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Sep 3rd, 2024 8:01 pm
Spruce Biosciences, Inc. (SPRB) Reports Q2 Loss, Tops Revenue Estimates - Aug 12th, 2024 9:10 pm
Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - Aug 12th, 2024 8:01 pm
Pipeline Moves: Approval prospects for BioTissue’s diabetic foot ulcer drug up after Phase III completion - Jun 24th, 2024 8:12 am
Spruce Biosciences Recognized as a Bay Area Best Place to Work - Jun 6th, 2024 12:00 pm
Nano-Cap Spruce Biosciences Collaborates With HMNC Brain Health To Develop Treatment for Major Depressive Disorder - Jun 4th, 2024 11:02 am
Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD) - Jun 4th, 2024 11:00 am
Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024 - Jun 3rd, 2024 11:00 am
Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference - May 23rd, 2024 8:05 pm
Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society - May 22nd, 2024 8:14 pm
Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, Tops Revenue Estimates - May 13th, 2024 9:10 pm
Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates - May 13th, 2024 8:01 pm